Specific Delivery of Captopril to the Kidney with the Prodrug Captopril-Lysozyme
Robbert J. Kok(Utrecht University), Dirk K. F. Meijer(University of Groningen), Dick de Zeeuw(University Medical Center Groningen), R.B. Walthuis, Frits Moolenaar(University of Groningen), F. Grijpstra(Target (United States))
Cited by 37
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k